Recent studies have shown that release of mitochondrial
cytochrome c is a critical step in the apoptosis process. We have reported that cytosolic redistribution of
cytochrome c in vivo occurred after transient focal
cerebral ischemia (FCI) in rats and preceded the peak of DNA fragmentation. Although the involvement of
reactive oxygen species in the cytosolic redistribution of
cytochrome c in vitro has been suggested, the detailed mechanism by which
cytochrome c release is mediated in vivo has not yet been established. Also, the role of mitochondrial oxidative stress in
cytochrome c release is unknown. These issues can be addressed using knock-out mutants that are deficient in the level of the mitochondrial
antioxidant manganese superoxide dismutase (
Mn-SOD). In this study we examined the subcellular distribution of the
cytochrome c protein in both wild-type mice and heterozygous knock-outs of the
Mn-SOD gene (Sod2 -/+) after permanent FCI, in which apoptosis is assumed to participate. Cytosolic
cytochrome c was detected as early as 1 hr after
ischemia, and correspondingly, mitochondrial
cytochrome c showed a significant reduction 2 hr after
ischemia (p < 0.01). Cytosolic accumulation of
cytochrome c was significantly higher in Sod2 -/+ mice compared with wild-type animals (p < 0.05). N-
benzyloxycarbonyl-val-ala-asp-fluoromethyl
ketone (
z-VAD.FMK), a nonselective
caspase inhibitor, did not affect
cytochrome c release after
ischemia. A significant amount of
DNA laddering was detected 24 hr after
ischemia and increased in Sod2 -/+ mice. These data suggest that
Mn-SOD blocks cytosolic release of
cytochrome c and could thereby reduce apoptosis after permanent FCI.